Targeting GIPC/Synectin in Pancreatic Cancer Inhibits Tumor Growth

TRANSLATIONAL RELEVANCE: The five year survival rate in patients with ductal adenocarcinoma of the pancreas is less than 4%. Accordingly, new targets for the treatment of this deadly disease are urgently needed. In this study, we show that targeting GAIP interacting protein C-terminal (GIPC, also kn...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Muders, Michael H., Vohra, Pawan K., Dutta, Shamit K, Wang, Enfeng, Ikeda, Yasuhiro, Wang, Ling, Udugamasooriya, D. Gomika, Memic, Adnan, Rupashinghe, Chamila N., Baretton, Gustavo B., Aust, Daniela E., Langer, Silke, Datta, Kaustubh, Simons, Michael, Spaller, Mark R., Mukhopadhyay, Debabrata
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2009
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731998/
https://ncbi.nlm.nih.gov/pubmed/19509165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2837
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन